| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 43 |
| 1 | METHOTREXATE SODIUM | 36 |
| 2 | ADALIMUMAB | 32 |
| 3 | METHOTREXATE | 32 |
| 4 | PEMBROLIZUMAB | 27 |
| 5 | SECUKINUMAB | 26 |
| 6 | CETUXIMAB | 24 |
| 7 | DOCETAXEL | 24 |
| 8 | DOCETAXEL ANHYDROUS | 24 |
| 9 | IBUPFROFEN | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BULEVIRTIDE | 1 | 0.0104 |
| 1 | MOISTURIZER | 1 | 0.0083 |
| 2 | LULICONAZOLE | 1 | 0.0057 |
| 3 | DELGOCITINIB | 1 | 0.0037 |
| 4 | ERAVACYCLINE | 1 | 0.0034 |
| 5 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 1 | 0.0033 |
| 6 | LEVOLEUCOVORIN INJECTION | 8 | 0.0026 |
| 7 | AFATINIB | 14 | 0.0021 |
| 8 | LEVOLEUCOVORIN | 8 | 0.0021 |
| 9 | ETHACRYNIC ACID | 1 | 0.0018 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 2 | Pyrethroid [EPC] | 2 | 0.0011 |
| 3 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 35 | 0.0007 |
| 5 | Interleukin-17A Antagonist [EPC] | 26 | 0.0007 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 7 | Human Immunoglobulin G [EPC] | 12 | 0.0006 |
| 8 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |